DURHAM, N.C. & SEATTLE-- November 13, 2023--Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection. The...
Panacos, Vitex Merging In $27M Stock Exchange, Plus Milestones (BioWorld Today)
News | 06. 04. 2004
Panacos Pharmaceuticals
Bringing together two infectious disease pipelines, Panacos Pharmaceuticals Inc. entered a definitive merger agreement with V.I. Technologies Inc., also called Vitex.
